121 related articles for article (PubMed ID: 29185589)
1. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases.
Lee SM; Lewanski CR; Counsell N; Ottensmeier C; Bates A; Patel N; Wadsworth C; Ngai Y; Hackshaw A; Faivre-Finn C
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25031274
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.
Xin Y; Guo W; Yang CS; Huang Q; Zhang P; Zhang LZ; Jiang G
Cancer Med; 2018 Apr; 7(4):981-990. PubMed ID: 29516684
[TBL] [Abstract][Full Text] [Related]
5. Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases.
Ryu WK; Cha HK; Kim W; Lee HY; Kim HJ; Ryu JS; Lim JH
Sci Rep; 2023 Aug; 13(1):13173. PubMed ID: 37580499
[TBL] [Abstract][Full Text] [Related]
6. RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
Gupta A; Roberts C; Tysoe F; Goff M; Nobes J; Lester J; Marshall E; Corner C; Wolstenholme V; Kelly C; Wise A; Collins L; Love S; Woodward M; Salisbury A; Middleton MR
Br J Cancer; 2016 Nov; 115(10):1193-1200. PubMed ID: 27711083
[TBL] [Abstract][Full Text] [Related]
7. Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
Chen TW; Dai MS; Tseng LM; Chen SC; Chao TY; Chao TC; Chang YC; Chiu CF; Liu CT; Lin CH; Liu CY; Chen YF; Chang DY; Yu JC; Rau KM; Hsieh YY; Shen SC; Huang SM; Cheng AL; Lu YS
JAMA Oncol; 2024 Mar; 10(3):325-334. PubMed ID: 38127335
[TBL] [Abstract][Full Text] [Related]
8. Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases.
Zhang K; Zhang T; Guo Z; Zhao F; Li J; Li Y; Li Y; Wu X; Chen X; Zhang W; Pang Q; Wang P
BMC Cancer; 2023 Dec; 23(1):1240. PubMed ID: 38104068
[TBL] [Abstract][Full Text] [Related]
9. G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases.
Luo S; Li P; Zhang A; Meng L; Huang L; Wu X; Cheng H; Tu H; Gong X
Int Immunopharmacol; 2024 Mar; 130():111705. PubMed ID: 38412673
[TBL] [Abstract][Full Text] [Related]
10. A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
Flores-Paco P; Vargas-Aliaga A; Guevara MG; Lopera I; Ruiz LR; López-Herrero M; Camús JA; López-González J; Inga-Saavedra E; Montero M; Barneto I; Gómez-España MA; Ruiz E; Ruza M; Armenta A; Palacios A; De La Haba-Rodríguez JR; Aranda E
J Neurooncol; 2024 May; 167(3):407-413. PubMed ID: 38539006
[TBL] [Abstract][Full Text] [Related]
11. Ipilimumab and whole brain radiation therapy for melanoma brain metastases.
Gerber NK; Young RJ; Barker CA; Wolchok JD; Chan TA; Yamada Y; Friguglietti L; Beal K
J Neurooncol; 2015 Jan; 121(1):159-65. PubMed ID: 25273687
[TBL] [Abstract][Full Text] [Related]
12. Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases.
Sakai K; Kuramoto J; Takahashi T; Kawano Y; Nishimura H; Kuwabara Y; Kojima A; Sasaki-Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Koyama N; Uematsu K
Anticancer Res; 2023 Nov; 43(11):5107-5114. PubMed ID: 37909984
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
[TBL] [Abstract][Full Text] [Related]
14. Cranial irradiation in adults diagnosed with acute myelogenous leukemia presenting with hyperleukocytosis and neurologic dysfunction.
Ferro A; Jabbour SK; Taunk NK; Aisner J; Cohler A; Somalya S; Goyal S
Leuk Lymphoma; 2014 Jan; 55(1):105-9. PubMed ID: 23734620
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review.
Luciano A; Liguori L; Polcaro G; Sabbatino F; Pepe S
Clin Pract; 2023 Nov; 13(6):1549-1560. PubMed ID: 38131685
[TBL] [Abstract][Full Text] [Related]
16. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
Niibe Y; Onda T; Matsuo K; Inoue Y; Hayakawa K
Anticancer Res; 2017 Dec; 37(12):6983-6988. PubMed ID: 29187484
[TBL] [Abstract][Full Text] [Related]
17. Study of gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma: A descriptive study.
Kumar R; Dubashi B; Kayal S; Lazzar SC; Barathi D; Kumar V
Indian J Cancer; 2017; 54(1):188-192. PubMed ID: 29199688
[TBL] [Abstract][Full Text] [Related]
18. CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
Wu YL; Ahn MJ; Garassino MC; Han JY; Katakami N; Kim HR; Hodge R; Kaur P; Brown AP; Ghiorghiu D; Papadimitrakopoulou VA; Mok TSK
J Clin Oncol; 2018 Sep; 36(26):2702-2709. PubMed ID: 30059262
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in
Noronha V; Patil VM; Joshi A; Menon N; Chougule A; Mahajan A; Janu A; Purandare N; Kumar R; More S; Goud S; Kadam N; Daware N; Bhattacharjee A; Shah S; Yadav A; Trivedi V; Behel V; Dutt A; Banavali SD; Prabhash K
J Clin Oncol; 2020 Jan; 38(2):124-136. PubMed ID: 31411950
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses.
Zhao B; Wang Y; Wang Y; Chen W; Zhou L; Liu PH; Kong Z; Dai C; Wang Y; Ma W
Aging (Albany NY); 2020 Jul; 12(14):14244-14270. PubMed ID: 32669477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
